Danaher (DHR) vs Revvity (RVTY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Revvity (RVTY) has outperformed Danaher (DHR) over the past year, gaining 65.8% versus a gain of 6.1%. Over five years, RVTY leads with a -10.4% price change compared with -18.6% for DHR. Danaher is the larger company by market cap ($152.87 billion vs $16.98 billion), about 9.0 times the size, while Revvity is growing revenue faster (+3.7% vs +2.9%).
On valuation, Danaher trades at a lower forward P/E (23.4x vs 25.8x for Revvity). Danaher offers the higher dividend yield (0.66% vs 0.18%). Danaher converts more of its revenue into profit, with a net margin of 14.7% versus 8.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DHR | RVTY |
|---|---|---|
| Share price | $217.46 | $152.16 |
| Market cap | $152.87B | $16.98B |
| 1-day change | -0.47% | -0.94% |
| YTD return | -5.01% | +57.27% |
| 1-year return | +6.10% | +65.81% |
| 5-year return | -18.61% | -10.40% |
| P/E ratio (TTM) | 38.76 | 72.80 |
| Forward P/E | 23.39 | 25.82 |
| EPS (TTM) | $5.61 | $2.09 |
| Dividend yield | 0.66% | 0.18% |
| Annual dividend | $1.44 | $0.28 |
| Revenue (latest FY) | $24.57B | $2.86B |
| Revenue growth (YoY) | +2.90% | +3.67% |
| Net income (latest FY) | $3.61B | $241.20M |
| Gross margin | 59.11% | — |
| Operating margin | 19.09% | 12.49% |
| Net margin | 14.71% | 8.45% |
| 52-week high | $242.80 | $166.25 |
| 52-week low | $160.93 | $81.22 |
| Distance from 52-week high | -10.44% | -8.48% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +9.93% | -10.71% |
| Average volume | 4.74M | 1.79M |
| Shares outstanding | 702.99M | 111.59M |
| Employees | 58,000 | 11,000 |
| Sector | Industrials | Industrials |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Danaher is about 9.0 times larger than Revvity by market value ($152.87B vs $16.98B).
- RVTY has outperformed DHR by 59.7 percentage points over the past year.
- Revvity trades at a higher earnings multiple (72.8x vs 38.8x trailing P/E).
- Danaher is more profitable, keeping 14.7 cents of every revenue dollar as net income versus 8.4 cents for Revvity.
About Danaher
DHR stock →Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.
Industrials · Industrial Machinery/Components · 58,000 employees
About Revvity
RVTY stock →Revvity, Inc. provides health sciences solutions, technologies, and services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 11,000 employees
DHR vs RVTY FAQ
Which is bigger, Danaher or Revvity?
Danaher (DHR) is larger, with a market capitalization of $152.87B compared with $16.98B for Revvity (RVTY).
Which stock has performed better over the past year, DHR or RVTY?
RVTY returned +65.81% over the past 12 months, compared with +6.10% for DHR (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DHR or RVTY?
DHR has the lower trailing P/E at 38.8, versus 72.8 for RVTY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Danaher or Revvity?
Danaher has the higher yield at 0.66%, compared with 0.18% for Revvity.
Are Danaher and Revvity in the same industry?
Both are in the Industrials sector, but in different industries: Industrial Machinery/Components for Danaher and Biotechnology: Laboratory Analytical Instruments for Revvity.